Patents by Inventor Paul Helman

Paul Helman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11718453
    Abstract: A pouring system comprising a spout retainer and a pour spout that form a liquid-tight seal when attached to, or disposed with respect to, a liquid container, such as a bottle, thereby reducing or eliminating losses from poor seals suffered by use of conventional pour spouts. A spout retainer is configured to forms an essentially liquid-proof seal with an open portion of a container and a pour spout inserted into the container.
    Type: Grant
    Filed: October 13, 2018
    Date of Patent: August 8, 2023
    Assignee: THE PURE POUR LLC
    Inventors: Daniel F. Andrews, Paul Helman
  • Publication number: 20210198016
    Abstract: A pouring system comprising a spout retainer and a pour spout that form a liquid-tight seal when attached to, or disposed with respect to, a liquid container, such as a bottle, thereby reducing or eliminating losses from poor seals suffered by use of conventional pour spouts. A spout retainer is configured to forms an essentially liquid-proof seal with an open portion of a container and a pour spout inserted into the container.
    Type: Application
    Filed: October 13, 2018
    Publication date: July 1, 2021
    Applicant: THE PURE POUR LLC
    Inventors: Daniel F. ANDREWS, Paul HELMAN
  • Publication number: 20090203588
    Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.
    Type: Application
    Filed: June 8, 2007
    Publication date: August 13, 2009
    Inventors: Cheryl L. Willman, Paul Helman, Robert Veroff, Monica Mosquera-Caro, George S. Davidson, Shawn B. Martin, Susan R. Atlas, Erik Andries, Huining Kang, Jonathan J. Shuster, Xuefei Wang, Richard C. Harvey, David M. Haaland, Jeffrey W. Potter
  • Publication number: 20060141504
    Abstract: The present invention relates to methods for predicting the outcome of therapeutic intervention in cases of leukemia, especially acute lymphoblastic leukemia in children and adults. The present invention evaluates a gene expression profile and identifies prognostic genes of cancers, in particular leukemia, more particularly B-precursor acute lymphoblastic leukemia (ALL). The present invention provides a method of determining prognosis of leukemia, in particular, acute lymphoblastic leukemia, more particularly B-precursor ALL and predicting therapeutic outcome of a patient. The method comprises the steps of first establishing the threshold value of at least three prognostic genes of leukemia, preferably at least eight prognostic genes, or preferably, as many as 26 prognostic genes. Then, the amount of the prognostic gene(s) from a leukemia patient is determined.
    Type: Application
    Filed: November 23, 2005
    Publication date: June 29, 2006
    Inventors: Cheryl Willman, Edward Bedrick, Huining Kang, Paul Helman, Robert Veroff
  • Publication number: 20060063156
    Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.
    Type: Application
    Filed: December 5, 2003
    Publication date: March 23, 2006
    Inventors: Cheryl Willman, Paul Helman, Robert Veroff, Monica Mosquera-Caro, George Davidson, Shawn Martin, Susan Atlas, Erik Andries, Huining Kang, Jonathan Shuster, Xuefei Wang, Richard Harvey, David Haaland, Jeffrey Potter